ANDA Approval by US FDA
Awaiting price reaction for this filing.
J.B. Chemicals & Pharmaceuticals has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Amitriptyline Hydrochloride Tablets in six strengths — 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg. This generic medication is used for the relief of symptoms of depression. The approval allows the company to manufacture and market this product in the US market. Amitriptyline is a widely used, established generic drug, which could help the company capture market share in the US generics space.
This is a positive development as it strengthens J.B. Chemicals' US product portfolio and opens up an additional revenue stream from the US generics market. However, the exact financial impact depends on the scale of opportunity and existing competition for this molecule.